This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Partial Anomalous Pulmonary Venous Connection, PAPVC부분 폐정맥연결이상

📋 Contents and key points
ItemDetails
A. Classification codesICD-10: Q26.3 (Partial anomalous pulmonary venous connection) | Special Copayment Reduction: V192 (Special copayment reduction for heart disease: 5% copayment for up to 30 days from the registration date)
B. SynonymsPartial anomalous pulmonary venous return (PAPVR), partial anomalous pulmonary venous connection, unilateral anomalous pulmonary venous connection
C. Adult onsetIt often remains asymptomatic and undetected until adulthood, and cases first diagnosed through exercise intolerance, right heart failure, or pulmonary hypertension are increasing. When Qp:Qs ≥1.5, surgical correction is considered even in adults.
1. HistoryFirst described in 18th-century autopsy reports, surgical attempts before cardiopulmonary bypass in the 1950s, followed by establishment of corrective techniques
2. CausesIncomplete incorporation of the primitive common pulmonary vein into the left atrium; ASD is commonly associated; includes scimitar syndrome
3. GeneticsMostly sporadic; NKX2.5 and GATA4 variants in some; may be associated with chromosomal abnormalities such as 22q11.2 deletion
4. General epidemiologyAutopsy frequency 0.4–0.7%; found in about 10% of patients with ASD; right lung origin twice as common as left lung
5. PathophysiologySome pulmonary veins → connection to the systemic venous system → left-to-right shunt → right heart volume overload → right heart failure and pulmonary hypertension
6. SymptomsChildhood: mostly asymptomatic; adults: dyspnea, exercise intolerance, palpitations, symptoms of right heart failure
7. SignsFixed splitting of S2, systolic pulmonary flow murmur, right ventricular heave, hepatomegaly, jugular venous distension
8. ScreeningConfirmatory testing proceeds after detection of abnormal chest radiograph findings or indirect signs on transthoracic echocardiography (right ventricular dilation)
9. DiagnosisCardiac CT and MRI are standard; transesophageal echocardiography has high sensitivity; Qp:Qs measured by cardiac catheterization if needed
10. TreatmentSurgical correction when Qp:Qs ≥1.5, right ventricular dilation, or symptoms are present; Warden procedure for the right upper pulmonary vein, etc.
11. PrognosisNormalization of right ventricular function after corrective surgery, favorable long-term prognosis; late complications of superior vena cava stenosis and arrhythmia in some
12. PreventionDetailed prenatal ultrasound examination, neonatal cardiac screening, genetic counseling for those with a family history
13. ReferencesMedical Management of Isolated Partial Anomalous Pulmonary Venous Connection With Symptomatic Right Ventricular Failure and Pulmonary Hypertension … and 9 other papers

1. History

The history of partial anomalous pulmonary venous connection (PAPVC) begins with the autopsy records of 18th-century anatomists. In 1739, Winslow first described a case in which the right pulmonary vein connected to the inferior vena cava, and sporadic autopsy reports followed over the subsequent decades. However, a systematic clinical understanding of the disease was achieved only in the 20th century.

In 1952, Dotter and Steinberg published the first case of PAPVC diagnosed during life using cardiac catheterization. This period coincides with the time when cardiac catheterization began to be actively used in the diagnosis of congenital heart malformations. In 1954, Muller first attempted surgical correction of PAPVC, but this operation, performed without full cardiopulmonary bypass, achieved only partial success.

In 1956, Kirklin et al. succeeded in complete correction of PAPVC associated with atrial septal defect using cardiopulmonary bypass, laying the foundation for surgical treatment. Subsequently, various surgical techniques were developed for scimitar syndrome (right pulmonary vein–inferior vena cava connection), including right upper pulmonary vein–superior vena cava connection.

In the 1970s–80s, along with the diversification of surgical techniques, tailored surgical strategies according to the anatomical subtype of PAPVC were established. In particular, for anomalous connection of the right upper pulmonary vein with superior vena cava sinus venosus-type ASD, the Warden procedure (creating a right atrium–left atrium tunnel through connection of the right upper pulmonary vein to the right atrium) was introduced and contributed to reducing the complication of superior vena cava stenosis.

Since the 1990s, the introduction of transesophageal echocardiography and advances in CT and MRI imaging technology have greatly improved the diagnostic accuracy of PAPVC. In particular, cardiac MRI can accurately measure the anatomy of the anomalously connected pulmonary veins and the shunt volume without radiation exposure, and has become an essential tool for evaluating adult PAPVC patients. In the 2020s, as case reports of latent PAPVC in adults have increased, PAPVC is being re-examined as a cause of right heart failure and pulmonary hypertension in the elderly population.


2. Causes

PAPVC occurs when the primitive common pulmonary vein is incompletely incorporated into the left atrium during embryonic development. Normally all pulmonary veins should be integrated into the left atrium, but some pulmonary veins are excluded from the overall absorption process and retain connections with the systemic venous system (superior vena cava, inferior vena cava, portal system, coronary sinus, right atrium, etc.).

The most common form is the type in which the right upper pulmonary vein connects to the superior vena cava or right atrium, accounting for 80–90% of all PAPVC. In this case it is often accompanied by a sinus venosus-type ASD. Anomalous connection of the left pulmonary veins is less common at about 10–20% of the total, and most connect to the left innominate vein via a left vertical vein.

Scimitar syndrome (right lung hypoplasia + right pulmonary vein–inferior vena cava connection) is a special subtype of PAPVC, characterized by a crescent-shaped (scimitar) anomalous venous shadow on the chest radiograph. This syndrome may be accompanied by right lung hypoplasia, anomalous systemic arterial supply, and right pulmonary sequestration. Atrial septal defect (ASD) is present in about 75% of PAPVC patients, of which sinus venosus-type ASD is the most common.


3. Genetics

PAPVC mostly occurs sporadically, and familial occurrence is rare. However, in some cases heterozygous variants in cardiac development-related transcription factor genes (NKX2.5, GATA4, TBX5) are found, and these genes play important roles in atrial septum formation and pulmonary vein development.

Among chromosomal abnormalities, 22q11.2 microdeletion is associated with some cases of PAPVC, and anomalous pulmonary venous connection is rarely seen in Turner syndrome (45,X) as well. In Holt-Oram syndrome (TBX5 gene variants), ASD and PAPVC co-occur more frequently than in the general population.

Sinus venosus-type defects in which PAPVC and ASD occur together are presumed to have a particularly strong genetic predisposition, and common molecular mechanisms of the cardiac developmental pathways are thought to be involved. Studies of various signaling pathways (Notch, Wnt, BMP) are under way to elucidate the molecular mechanisms of this disease.


4. General epidemiology

The prevalence of PAPVC is estimated at 0.4–0.7% in autopsy studies and is reported to be lower in echocardiography-based studies. This is because many patients are asymptomatic and live their whole lives undiagnosed. PAPVC is present in about 10% of patients with confirmed ASD, and the rate of associated PAPVC is higher especially with sinus venosus-type ASD.

PAPVC of right lung origin is about twice as common as that of left lung origin, suggesting that failure of incorporation into the left atrium occurs more frequently during the development of the right lung. Some studies report a tendency toward a slightly higher frequency in women, but there is no consistent conclusion yet.

The frequency of detection in adults is gradually increasing, reflecting more cases in which previously missed PAPVC is discovered incidentally with the spread of cardiac CT and MRI. In particular, PAPVC is increasingly identified as the cause in middle-aged and older adults presenting with unexplained right heart failure or pulmonary hypertension.


5. Pathophysiology

In PAPVC, one or more pulmonary veins connect to the systemic venous system instead of the left atrium, so oxygenated blood from the affected lung flows into the right atrium. This forms a net left-to-right shunt, increasing the volume load on the right atrium and right ventricle. The size of the shunt (Qp:Qs ratio) is determined by the number of anomalously connected pulmonary veins and the size of any associated ASD.

Persistent right heart volume overload causes enlargement of the right atrium and right ventricle, which may in turn lead to tricuspid regurgitation and a gradual rise in pulmonary artery pressure (pulmonary hypertension). As pulmonary vascular lesions (Heath-Edwards classification) progress over decades, pulmonary vascular resistance can increase irreversibly, resulting in reversal to a right-to-left shunt (Eisenmenger syndrome).

When the shunt is small (Qp:Qs < 1.5), there may be no symptoms for decades, but when Qp:Qs exceeds ≥1.5, the risk of right heart failure symptoms, reduced exercise capacity, and atrial fibrillation increases. Early correction before pulmonary hypertension is established is advantageous for recovery of right ventricular function and normalization of the pulmonary vasculature.


6. Symptoms

Most cases are asymptomatic in childhood, and cardiomegaly or increased pulmonary vascular markings are often found incidentally on chest radiographs at health checkups. With a large shunt, recurrent respiratory infections, growth failure, and exertional dyspnea may occur even in childhood.

In adulthood, exercise intolerance, dyspnea, and palpitations are the most common symptoms. When diagnosis is delayed, symptoms of right heart failure (lower limb edema, ascites, jugular venous distension) and symptoms due to pulmonary hypertension are present. Premature atrial contractions or atrial fibrillation occur in association with chronic right atrial enlargement and increase the risk of stroke (paradoxical embolism). In some patients with scimitar syndrome, recurrent pneumonia of the right lung occurs.


7. Signs

On physical examination, fixed splitting of the second heart sound (S2) is characteristic, reflecting delayed pulmonary valve closure due to right ventricular dilation. A systolic ejection murmur is heard at the pulmonic auscultation area, and with tricuspid regurgitation, a systolic regurgitant murmur is additionally heard at the tricuspid area. A right ventricular heave may be palpable at the lower left sternal border.

On the chest radiograph, right atrial and right ventricular enlargement and increased pulmonary vascular markings are observed. In scimitar syndrome, a crescent-shaped anomalous venous shadow in the lower right lung is characteristic. With pulmonary hypertension, pulmonary artery enlargement and peripheral vascular pruning appear. On the electrocardiogram, incomplete right bundle branch block (RBBB), right axis deviation, and right ventricular hypertrophy are observed.


8. Screening

Transthoracic echocardiography (TTE) is useful for finding indirect signs of right heart volume overload rather than for directly diagnosing PAPVC. PAPVC should be considered in the differential diagnosis when right ventricular enlargement, right atrial enlargement, elevated right ventricular systolic pressure, paradoxical motion of the interventricular septum, etc. are observed. The likelihood of PAPVC is particularly high when these findings are present even though no ASD is seen.

Chest radiography is a first-line screening tool, prompting further testing when right heart enlargement and increased pulmonary vascular markings are found. In scimitar syndrome in particular, suspicion is possible from the chest radiograph alone. When there are ECG abnormalities (RBBB, right axis deviation), echocardiography should be performed to differentiate right heart disease.


9. Diagnosis

Cardiac CT angiography (CTA) and cardiac MRI (CMR) are the standard tests for confirming PAPVC. These tests make it possible to determine in three dimensions the exact anatomical location, course, and connection site of the anomalously connected pulmonary veins, and CMR additionally provides quantitative assessment of the Qp:Qs ratio, right ventricular volume and function, and pulmonary artery pressure.

Transesophageal echocardiography (TEE) shows excellent sensitivity in visualizing pulmonary venous connection sites and can be performed on an outpatient basis under moderate sedation. In particular, TEE is superior to TTE in diagnosing anomalous connection of the right upper pulmonary vein with sinus venosus-type ASD. Cardiac catheterization is performed when measurement of Qp:Qs and pulmonary vascular resistance or assessment of the vasoreactivity of pulmonary arterial hypertension is needed.


10. Treatment

The indication for surgical correction is Qp:Qs ≥1.5 with right ventricular enlargement or symptoms. Correction is recommended when pulmonary vascular resistance is less than 1/3 of systemic vascular resistance and pulmonary artery systolic pressure is less than 50% of systemic systolic pressure. Even in asymptomatic cases with Qp:Qs ≥1.5, prophylactic correction may be considered to prevent pulmonary vascular disease.

Surgical techniques differ according to the location of the anomalous connection. The Warden procedure is standard for correcting the most common right upper pulmonary vein–superior vena cava connection: the superior vena cava is divided and reanastomosed to the right atrial appendage, and the upper pulmonary vein–right atrium connection is rerouted to the left atrium with an intra-atrial baffle. In scimitar syndrome, the pulmonary vein is reimplanted or connected to the left atrium through an intra-atrial tunnel. Surgical outcomes are generally good, with mortality below 1–2%.

Medical management, in patients with small shunts or high surgical risk, includes relief of right heart failure symptoms (diuretics, digitalis) and treatment of pulmonary hypertension (PDE-5 inhibitors, endothelin receptor antagonists). When atrial fibrillation is present, anticoagulation and cardioversion are considered.


11. Prognosis

When early correction is performed, the prognosis is very good. After surgery, right ventricular size and function often normalize within several months, and long-term survival is similar to that of the general population. In scimitar syndrome, the risk of recurrent right lung pneumonia decreases after surgery, and growth and development improve.

Improvement in right ventricular function is observed even when correction is performed in adulthood, but long-standing pulmonary vascular changes may not fully recover. Long-term complications reported include superior vena cava stenosis (after the Warden procedure), atrial fibrillation, and atrial dyssynchrony, so regular follow-up by a cardiologist is needed even after surgery. When the disease has progressed to Eisenmenger physiology, surgical correction is not possible, and lung transplantation is the only curative treatment.


12. Prevention

Primary prevention of PAPVC is currently not possible, but early detection and correction at the appropriate time are key to preventing pulmonary vascular disease and suppressing the development of right heart failure. When there is a family history, genetic counseling and detailed prenatal echocardiography are recommended. In patients who already have a cardiac malformation, the presence of associated PAPVC must be checked.

In adults, when there is no cause for unexplained right heart failure, pulmonary hypertension, or atrial fibrillation, actively including PAPVC in the differential diagnosis is important to prevent diagnostic delay. General principles for preventing congenital heart disease are followed, such as preventing infection in pregnant women (rubella vaccination), controlling diabetes, and avoiding teratogenic drugs.


13. References

  1. Bravo-Valenzuela NJ, Oliveira EA, Araújo Júnior E. Medical management of isolated partial anomalous pulmonary venous connection with symptomatic right ventricular failure and pulmonary hypertension. SAGE Open Med Case Rep. 2024;12:2050313X241258362. DOI: 10.1177/2050313X241258362. PMID: 38957726.

  2. Vida VL, Padalino MA, Boccuzzo G, et al. Scimitar syndrome: a European Congenital Heart Surgeons Association (ECHSA) multicentric study. Circulation. 2010;122(12):1159-1166. DOI: 10.1161/CIRCULATIONAHA.109.926204. PMID: 20823381.

  3. Majdalany DS, Phillips SD, Dearani JA, et al. Isolated partial anomalous pulmonary venous connections in adults: twenty-year experience. Congenit Heart Dis. 2010;5(6):537-545. DOI: 10.1111/j.1747-0803.2010.00427.x. PMID: 21087438.

  4. Alsoufi B, Cai S, Van Arsdell GS, et al. Outcomes after surgical treatment of children with partial anomalous pulmonary venous connection. Ann Thorac Surg. 2007;84(6):2020-2026. DOI: 10.1016/j.athoracsur.2007.07.013. PMID: 18036926.

  5. Davia JE, Cheitlin MD, Bedynek JL. Sinus venosus atrial septal defect: analysis of fifty cases. Am Heart J. 1973;85(2):177-185. DOI: 10.1016/0002-8703(73)90124-5. PMID: 4683080.

  6. Gustafson RA, Warden HE, Murray GF, Murtagh CA. Partial anomalous pulmonary venous connection to the right side of the heart. J Thorac Cardiovasc Surg. 1989;98(5):861-868. DOI: 10.1016/S0022-5223(19)34459-2. PMID: 2585011.

  7. Porres DV, Morenza OP, Pallisa E, et al. Learning from the pulmonary veins. Radiographics. 2013;33(4):999-1022. DOI: 10.1148/rg.334125156. PMID: 23842972.

  8. Earing MG, Gill EA, Cabalka AK, et al. Intracardiac echocardiography during transcatheter closure of the partial anomalous pulmonary venous connection. J Am Coll Cardiol. 2007;50(1):91-94. DOI: 10.1016/j.jacc.2007.04.006. PMID: 17601548.

  9. Reidy JF, Baker EJ, Tynan MJ. Transcatheter occlusion of a right partial anomalous pulmonary venous connection. Br Heart J. 1990;64(6):391-393. DOI: 10.1136/hrt.64.6.391. PMID: 2278834.

  10. Ammash NM, Seward JB, Warnes CA, et al. Partial anomalous pulmonary venous connection: diagnosis by transesophageal echocardiography. J Am Coll Cardiol. 1997;29(6):1351-1358. DOI: 10.1016/s0735-1097(97)82758-1. PMID: 9137235.